A study on indices of apixaban anticoagulation: A single-center prospective study

A study on indices of apixaban anticoagulation: A single-center prospective study

Background: Depending on the characteristics of patients, the blood concentration of apixaban can unexpectedly increase, possibly leading to bleeding events. Anti-FXa activity reflects the apixaban blood concentration; however, measurement of this activity is both time-consuming and expensive. The c...

Full description

Bibliographic Details
Main Authors:	Maki Komiyama, Yusuke Miyazaki, Hiromichi Wada, Moritake Iguchi, Mitsuru Abe, Hisashi Ogawa, Masaharu Akao, Hajime Yamakage, Noriko Satoh-Asahara, Yoichi Sunagawa, Tatsuya Morimoto, Koji Hasegawa
Format:	Article
Language:	English
Published:	Elsevier 2018-06-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861318300823

Similar Items

The effect of highly absorbed curcumin on an oxidized LDL in patients with COPD
by: Masafumi Funamoto, et al.
Published: (2019-10-01)

Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation.
by: Maki Komiyama, et al.
Published: (2018-01-01)

Serum levels of Cystatin C, a sensitive marker of cardiovascular disease: Decrease after smoking cessation
by: Ayumi Katayama, et al.
Published: (2019-10-01)

The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan
by: Maki Komiyama, et al.
Published: (2018-10-01)

Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
by: Masafumi Funamoto, et al.
Published: (2019-01-01)

Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessation
by: Maki Komiyama, et al.
Published: (2021-06-01)

Analysis of factors that determine weight gain during smoking cessation therapy.
by: Maki Komiyama, et al.
Published: (2013-01-01)

ORAL ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS: FOCUS ON APIXABAN
by: M. Yu. Gilyarov, et al.
Published: (2017-12-01)

Anticoagulant activity of apixaban can be estimated by multiple regression analysis
by: Naoko Unami, et al.
Published: (2020-12-01)

Sustained resolution of anticoagulation related iron deficiency anemia with the use of apixaban
by: Alex Choo, et al.
Published: (2020-01-01)

Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD
by: Funamoto M, et al.
Published: (2016-08-01)

Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
by: Jayasree Pillarisetti, et al.
Published: (2020-11-01)

Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile
by: Z A Fazeel
Published: (2016-01-01)

Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.
by: Yasuhiro Hamatani, et al.
Published: (2015-01-01)

Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy
by: Sergey V. Brodsky, et al.
Published: (2017-12-01)

Evaluating the Efficacy and Safety of Apixaban, a New Oral Anticoagulant, using Bayesian Meta-Analysis
by: Ross, Daniel, et al.
Published: (2013)

A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting
by: Frydman, Galit H., et al.
Published: (2020)

Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice
by: Masashi Tanaka, et al.
Published: (2020-04-01)

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.
by: Lisa A de Jong, et al.
Published: (2019-01-01)

Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
by: Maki Komiyama, et al.
Published: (2020-08-01)

Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2α–ATF4 Pathway in Mouse Microglia
by: Takayuki Inoue, et al.
Published: (2019-05-01)

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
by: Hajime Yamakage, et al.
Published: (2020-05-01)

Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes
by: Yoichi Sunagawa, et al.
Published: (2018-04-01)

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
by: Kana Shimizu, et al.
Published: (2019-07-01)

Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease
by: Eric Wenzler, et al.
Published: (2020-10-01)

Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects.
by: Hiromichi Wada, et al.
Published: (2011-01-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

The use of apixaban as a perioperative bridge for warfarin in a patient unable to use parenteral anticoagulation: A case report
by: Eric A. Dietrich, et al.
Published: (2021-08-01)

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
by: Gregory Y H Lip, et al.
Published: (2018-01-01)

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
by: Asami Ikeda, et al.
Published: (2020-11-01)

International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
by: Fanny Ofek, et al.
Published: (2019-10-01)

Case Report of a Massive Thigh Hematoma after Adductor Canal Block in a Morbidly Obese Woman Anticoagulated with Apixaban
by: Katherine L. Koniuch, et al.
Published: (2018-01-01)

APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN
by: O. D. Ostroumova, et al.
Published: (2018-07-01)

Quick reference guide to apixaban
by: Hurst KV, et al.
Published: (2017-07-01)

Apixaban-Induced Skin Purpura
by: Miryam Moreta Rodríguez, et al.
Published: (2021-09-01)

Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
by: Andrea Huppertz, et al.
Published: (2019-08-01)

Direct monitoring of mitochondrial calcium levels in cultured cardiac myocytes using a novel fluorescent indicator protein, GCaMP2-mt.
by: Iguchi, Moritake
Published: (2011)

APIXABAN – FROM RECOMMENDATIONS TO EVERYDAY PRACTICE
by: L. N. ELISEEVA, et al.
Published: (2016-12-01)

Apixaban linearity profile for hydrotropic solubilization
by: Santosh Karajgi, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_37ae2idtpg67o29cmkvkjm2lf7